Inside these posts: Injectable drugs

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


Hospira profits tumble 40% on quality issues, sales

Shares of Hospira Inc. lost 7 percent of their value after the company said fourth-quarter profits fell nearly 40 percent, as the maker of drugs and devices works to improve product quality in the wake of regulatory issues.

Hospira had lower-than-anticipated fourth quarter sales because it has been unable to deliver products to customers fast enough due largely to “quality enhancement initiatives.” Get the full story »